Caffeine intake, smoking, and risk of Parkinson disease in men and women. - Wikidata - wikimedia - TriplyDB

Caffeine intake, smoking, and risk of Parkinson disease in men and women.

Caffeine intake, smoking, and risk of Parkinson disease in men and women.

http://www.wikidata.org/entity/Q36019163

about

Dietary fat intake and risk for Parkinson's disease Association between Parkinson's Disease and Cigarette Smoking, Rural Living, Well-Water Consumption, Farming and Pesticide Use: Systematic Review and Meta-Analysis Association between caffeine consumption and nonalcoholic fatty liver disease: a systemic review and meta-analysis Dietary factors in the etiology of Parkinson's disease.Parkinson's Disease and Its Management: Part 1: Disease Entity, Risk Factors, Pathophysiology, Clinical Presentation, and Diagnosis Do physical exercise and reading reduce the risk of Parkinson's disease? a cross-sectional study on factors associated with Parkinson's disease in elderly Chinese veterans Coffee consumption in NAFLD patients with lower insulin resistance is associated with lower risk of severe fibrosis.Decreased circulating Zinc levels in Parkinson's disease: a meta-analysis study Role of microglia adenosine A(2A) receptors in retinal and brain neurodegenerative diseases.Parkinson's disease: no milk today?Dose-response meta-analysis on coffee, tea and caffeine consumption with risk of Parkinson's disease.MDS research criteria for prodromal Parkinson's disease.Sweetened beverages, coffee, and tea and depression risk among older US adults A case-control study of the protective effect of alcohol, coffee, and cigarette consumption on Parkinson disease risk: time-since-cessation modifies the effect of tobacco smoking Serum biomarkers of habitual coffee consumption may provide insight into the mechanism underlying the association between coffee consumption and colorectal cancer Lifestyle, family history, and risk of idiopathic Parkinson disease: a large Danish case-control study.Head injury, potential interaction with genes, and risk for Parkinson's disease.Chronic obstructive pulmonary disease, hospital visits, and comorbidities: National Survey of Residential Care Facilities, 2010.Associations of Coffee Drinking with Systemic Immune and Inflammatory Markers.Intakes of caffeine, coffee and tea and risk of amyotrophic lateral sclerosis: Results from five cohort studies.Multiple Sclerosis Associated Risk Factors: A Case-Control Study.Reengineering the collision coupling and diffusion mode of the A2A-adenosine receptor: palmitoylation in helix 8 relieves confinement.Neuroprotection by caffeine in the MPTP model of parkinson's disease and its dependence on adenosine A2A receptors.High consumption of coffee is associated with decreased multiple sclerosis risk; results from two independent studies.Lobeline shows protective effects against MPTP-induced dopaminergic neuron death and attenuates behavior deficits in animals.Polyphenol-Retaining Decaffeinated Cocoa Powder Obtained by Supercritical Carbon Dioxide Extraction and Its Antioxidant Activity.Susceptibility loci for pigmentation and melanoma in relation to Parkinson's disease.Long-term exposure to air pollution and the incidence of Parkinson's disease: A nested case-control study.Health benefits of methylxanthines in neurodegenerative diseases.The neuroprotective effects of caffeine in neurodegenerative diseases.Coffee Drinking Is Widespread in the United States, but Usual Intake Varies by Key Demographic and Lifestyle Factors.Trends in the Incidence of Parkinson Disease in the General Population: The Rotterdam Study.Association of Coffee Consumption With Overall and Cause-Specific Mortality in a Large US Prospective Cohort Study.The Changing Landscape of Parkinson Epidemiologic Research.Differences in Parkinson's Disease Risk with Caffeine Intake and Postmenopausal Hormone Use.Coffee Intake and Liver Steatosis: A Population Study in a Mediterranean Area.Interaction between caffeine and polymorphisms of glutamate ionotropic receptor NMDA type subunit 2A (GRIN2A) and cytochrome P450 1A2 (CYP1A2) on Parkinson's disease risk.In vitro pharmacological profile of the A2A receptor antagonist istradefylline.Caffeine drinking, cigarette smoking, and dopaminergic replacement therapy dose in Parkinson's disease.Beneficial Role of Coffee and Caffeine in Neurodegenerative Diseases: A Minireview.

P2860

Q23914947-93F72CF8-18D9-444E-B154-AA44EEAEBB85 Q24282619-B746212E-2296-49DB-9738-9075912A9524 Q26771874-CD96D648-9D15-4668-9C1C-DF60B77112F7 Q28085390-F746D981-0F14-4706-9325-BBB73BEA43E1 Q28384572-C41118A3-133D-4F2C-A7C7-1554FD877B95 Q28390370-7DF97DE4-5018-48C0-B5A9-502176EEAA12 Q33568261-27DB12ED-19EF-4C89-8CE5-6BCC1DBBD1AB Q33819153-DCDF6EEC-59E0-4E81-8694-4C6B07697A1B Q34014053-6F58CDE0-AB7B-41FE-84BD-6E32C4808267 Q34139664-BBCA9D18-225E-4068-A03D-C327C8ECABFE Q34359390-79F02E13-E403-4341-A29B-3D703D077FBD Q34498279-0F7A5445-53BD-4609-9073-AC08FCED29D0 Q35151652-17241FC0-4F35-49EE-855E-97D663C80482 Q35161661-59C810E9-8FED-4A76-B3E3-01091AFB1ADC Q35537836-B9A97166-D4FA-4652-8E8F-C434B30BF0DA Q35580323-F13F753B-67A1-489A-A2A6-DE86E917C7FE Q35595812-575B1A80-8AAA-4342-AFAC-9CC30E6941B7 Q35636099-52B102DC-B698-47F4-9D06-B78FD0833EE8 Q35815652-B5C2047E-FC7F-4B87-87A2-8C756DA43A70 Q36108811-A95E1EF3-1B9F-4F49-824E-B52D44D49430 Q36436093-8F317947-90A5-455E-A86A-06C63E232688 Q36451989-7066F47F-CA09-4571-B168-CC1B2F4E39A3 Q36723079-91AD34EE-59F9-44F0-9360-650F6F273944 Q36859515-6A3B1E46-2710-4D89-8D7D-74AC2EF9C821 Q37434541-66A7EA40-3F9E-423A-A652-DDB083ECF794 Q37635946-CF1836F3-5CDE-4B0C-AD42-AA67C937F101 Q37652816-5017A067-95A7-4F90-8CE7-DB663ED5DF9F Q38623836-F4A8AC70-8295-4624-9670-1FCD9E10150A Q38772021-0F77A631-C4BB-477B-9F00-F16F125F6D59 Q39186884-E4F55E2D-1A7B-4F39-8B48-356B197E3FB5 Q39526982-C16BF28F-F457-4496-A526-387A7A775226 Q39759171-6AB0C2C8-BC83-463D-8935-62B620AE300A Q40266558-D770BADE-1F8E-4AC5-A1DA-F0A0F79FBB92 Q47662113-A9A97C31-6737-4AF5-B403-DA4442A9A4CA Q47851272-EAED02EC-542C-4FAA-83CA-04310960AA01 Q48225600-767AB1B0-F0A5-4880-94AD-4A1162F622FE Q48520930-8B218E27-07C9-4930-84C4-941256D5CD4C Q50868357-0BC4A05E-7E26-4491-BB92-50F216344765 Q50913570-FFCFFEA5-3F93-4452-A0C3-CFFEAA601A2D Q54572410-B7C3EBFE-838F-4018-9854-65A720B8C9B1

P2860

Caffeine intake, smoking, and risk of Parkinson disease in men and women.

http://www.wikidata.org/entity/Q36019163

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Caffeine intake, smoking, and risk of Parkinson disease in men and women.

@ast

Caffeine intake, smoking, and risk of Parkinson disease in men and women.

@en

type

label

Caffeine intake, smoking, and risk of Parkinson disease in men and women.

@ast

Caffeine intake, smoking, and risk of Parkinson disease in men and women.

@en

prefLabel

Caffeine intake, smoking, and risk of Parkinson disease in men and women.

@ast

Caffeine intake, smoking, and risk of Parkinson disease in men and women.

@en

P1433

Q36019163-2289B3E8-8B89-46A1-8FED-B773C2A22632

P1476

Q36019163-D33324AB-4913-4F2D-A29B-1BF32442315E

P2093

Q36019163-32FBD020-6658-44F4-A713-BFCF9F70B1AB

Q36019163-3643378F-D9FF-4294-BB4C-63551A688320

Q36019163-41E7F8D6-27CD-464D-B5FC-8B4F92F93BD4

Q36019163-C770B8BF-7D8C-4791-AFCA-55A54C0F58C5

Q36019163-CD43E826-3278-4774-B098-966CB8AF6303

Q36019163-FFF24D5F-ED6D-4A10-B239-C50A41382582

P2860

Q36019163-0EEE5822-D38B-48BB-B961-B266FD266B4C

Q36019163-120947C9-4D88-4945-86E5-B0CDDDCC55E9

Q36019163-14E57A76-8780-4BF4-88B0-4088DB306EE3

Q36019163-2328D117-F418-4B47-ABEE-C753447CD503

Q36019163-27579B32-724D-4BD5-A8E6-40A2B5A0075B

Q36019163-366DBDC4-004E-4604-BEDD-4B54860E53AE

Q36019163-4C1F439F-D75E-4A46-B2C9-1A51EAB687C9

Q36019163-51E81CB8-59AC-46B9-9451-ECD496ED025D

Q36019163-641470A9-1149-4F0F-843C-EAA05178D9BD

Q36019163-67FF6B8F-03A1-45F0-AF5A-29660E54AAB8

P304

Q36019163-EA036146-56C8-42AA-998E-A73722B47CAA

P31

Q36019163-3AA509F5-5546-475F-B037-B2BEC5599F96

Q36019163-7a548849-f996-4a10-813b-8274b124957d

P356

Q36019163-74BBAF93-0C40-4DAF-83CA-5766AEC78166

P407

Q36019163-95EF0424-62F2-4478-ACC0-3DED437DC1B9

P433

Q36019163-32336A58-D350-4874-8647-137C3C4E8D98

P478

Q36019163-45E60B21-AD8F-4AB2-B495-FBF23BCFF0A3

P50

Q36019163-79B347D4-0E0F-4D35-930B-B64616A1FCD1

Q36019163-9CD0C189-69C6-486A-B6CC-258153D187AE

Q36019163-F2A9605D-DA1C-4523-9D46-FEF5F12BFE44

P577

Q36019163-EDC8FB94-7ABD-4BE2-B3AF-29E18B96CA04

P5875

Q36019163-E17F0EDD-A49D-4F2A-8AAC-27021B76CE7E

P698

Q36019163-E1745D89-8E03-4280-895E-3BB0135E6F2C

P921

Q36019163-44877190-F1DC-4A37-8384-CF07479630BB

P932

Q36019163-0E832913-EDDE-4A61-9705-F43ECFA57993

P356

P1433

American Journal of Epidemiology

P1476

Caffeine intake, smoking, and risk of Parkinson disease in men and women.

@en

P2093

Aaron Blair

http://www.w3.org/2001/XMLSchema#string

Albert R Hollenbeck

http://www.w3.org/2001/XMLSchema#string

Neal D Freedman

http://www.w3.org/2001/XMLSchema#string

Rashmi Sinha

http://www.w3.org/2001/XMLSchema#string

Rui Liu

http://www.w3.org/2001/XMLSchema#string

Xuguang Guo

http://www.w3.org/2001/XMLSchema#string

P2860

Quantifying heterogeneity in a meta-analysis

Meta-analysis in clinical trials

Smoking duration, intensity, and risk of Parkinson disease

Caffeine exposure and the risk of Parkinson's disease: a systematic review and meta-analysis of observational studies.

Association of coffee and caffeine intake with the risk of Parkinson disease.

Prospective study of caffeine consumption and risk of Parkinson's disease in men and women.

A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease.

Caffeinated clues and the promise of adenosine A(2A) antagonists in PD.

Relationship between impulsive sensation seeking traits, smoking, alcohol and caffeine intake, and Parkinson's disease

Drug interactions and smoking: raising awareness for acute and critical care providers.

P304

1200-1207

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/AJE/KWR451

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

175

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-04-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224039516

http://www.w3.org/2001/XMLSchema#string

P698

22505763

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

3370885

http://www.w3.org/2001/XMLSchema#string